OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
OX40 in the Pathogenesis of Atopic Dermatitis—A New Therapeutic Target
Michael Croft, Ehsanollah Esfandiari, Camilla Chong, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 3, pp. 447-461
Open Access | Times Cited: 31
Michael Croft, Ehsanollah Esfandiari, Camilla Chong, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 3, pp. 447-461
Open Access | Times Cited: 31
Showing 26-50 of 31 citing articles:
Anti-OX40 Biological Therapies in the Treatment of Atopic Dermatitis: A Comprehensive Review
Myriam Marfil-Cantón, Álvaro Prados‐Carmona, Marta Cebolla‐Verdugo, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 22, pp. 6925-6925
Open Access | Times Cited: 1
Myriam Marfil-Cantón, Álvaro Prados‐Carmona, Marta Cebolla‐Verdugo, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 22, pp. 6925-6925
Open Access | Times Cited: 1
Comparison of CD30L and OX40L Reveals CD30L as a Promising Therapeutic Target in Atopic Dermatitis
Rinkesh Kumar Gupta, Daniela Salgado Figueroa, Ferhat Ay, et al.
Allergy (2024) Vol. 80, Iss. 2, pp. 500-512
Closed Access | Times Cited: 1
Rinkesh Kumar Gupta, Daniela Salgado Figueroa, Ferhat Ay, et al.
Allergy (2024) Vol. 80, Iss. 2, pp. 500-512
Closed Access | Times Cited: 1
American Academy of Dermatology Annual Meeting: San Diego, CA, USA, 8–12 March 2024
Kathy A Fraser
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 3, pp. 509-512
Closed Access | Times Cited: 1
Kathy A Fraser
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 3, pp. 509-512
Closed Access | Times Cited: 1
Durable improvements in atopic dermatitis in the head and neck and across other anatomic regions with rocatinlimab
Emma Guttman‐Yassky, Ehsanollah Esfandiari, Hirotaka Mano, et al.
Archives of Dermatological Research (2024) Vol. 316, Iss. 10
Open Access
Emma Guttman‐Yassky, Ehsanollah Esfandiari, Hirotaka Mano, et al.
Archives of Dermatological Research (2024) Vol. 316, Iss. 10
Open Access
A Narrative Review of the OX40-OX40L Pathway as a Potential Therapeutic Target in Atopic Dermatitis: Focus on Rocatinlimab and Amlitelimab
Asaad Abdelhalim, Orhan Yilmaz, Mohamed Elshaikh Berair, et al.
Dermatology and Therapy (2024)
Open Access
Asaad Abdelhalim, Orhan Yilmaz, Mohamed Elshaikh Berair, et al.
Dermatology and Therapy (2024)
Open Access
Effects of Huang-Lian-Jie-Du decoction on improving skin barrier function and modulating T helper cell differentiation in 1-chloro-2,4-dinitrobenzene-induced atopic dermatitis mice
H. Zhang, Q. Li, Yaxing Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
H. Zhang, Q. Li, Yaxing Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Exploring the Potential Causal Relationship between Protein Ratio and Atopic Dermatitis Using a Two-Sample Mendelian Randomization Approach
Shubao Tian, Mansoo Yu, Jingjing Liu, et al.
Research Square (Research Square) (2024)
Closed Access
Shubao Tian, Mansoo Yu, Jingjing Liu, et al.
Research Square (Research Square) (2024)
Closed Access
The Ligands of the Tumor Necrosis Factor Superfamily and Their Receptors
Harald Wajant
Elsevier eBooks (2024)
Closed Access
Harald Wajant
Elsevier eBooks (2024)
Closed Access
